alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### §9132. Payroll support program

#### (a) In General

The Secretary shall establish a payroll support program and enter into agreements with employers who meet the eligibility criteria specified in subsection (b) and are not ineligible under subsection (c), to provide public contributions to supplement compensation of an eligible employee group. There is appropriated for fiscal year 2021, out of amounts in the Treasury not otherwise appropriated, $3,000,000,000, to remain available until September 30, 2023, for the Secretary to carry out the payroll support program authorized under the preceding sentence for which 1 percent of the funds may be used for implementation costs and administrative expenses.

#### (b) Eligibility

The Secretary shall enter into an agreement and provide public contributions, for a term no longer than 6 months, solely with an employer that agrees to use the funds received under an agreement exclusively for the continuation of employee wages, salaries, and benefits, to maintain the total compensation level for the eligible employee group as of April 1, 2020 for the duration of the agreement, and to facilitate the retention, rehire, or recall of employees of the employer, except that such funds may not be used for back pay of returning rehired or recalled employees.

#### (c) Ineligibility

The Secretary may not enter into any agreement under this section with an employer who was allowed a credit under section 2301 of the CARES Act (26 U.S.C. 3111 note) for the immediately preceding calendar quarter ending before such agreement is entered into, who received financial assistance under section 9073 of this title, or who is currently expending financial assistance under the paycheck protection program established under section 636(a)(36) of this title, as of the date the employer submits an application under the payroll support program established under subsection (a).

#### (d) Reductions

To address any shortfall in assistance that would otherwise be provided under this part, the Secretary shall reduce, on a pro rata basis, the financial assistance provided under this part.

#### (e) Agreement Deadline

No agreement may be entered into by the Secretary under the payroll support program established under subsection (a) after the last day of the 6 month period that begins on the effective date of the first agreement entered into under such program.

(Pub. L. 117–2, title VII, §7202, Mar. 11, 2021, 135 Stat. 103.)

#### **Editorial Notes**

#### References in Text

Section 2301 of the CARES Act, referred to in subsec. (c), is section 2301 of Pub. L. 116–136, which is set out as a note under section 3111 of Title 26, Internal Revenue Code.

#### Codification

Section was enacted as part of the American Rescue Plan Act of 2021, and not as part of the CARES Act which in part comprises this chapter.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
"THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF GEORGIA-PACIFIC CORPORATION FOR THE 12 MONTHS ENDED
DECEMBER 31, 1996, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS."
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                              10
<SECURITIES>                                         0
<RECEIVABLES>                                      969
<ALLOWANCES>                                        10
<INVENTORY>                                      1,467
<CURRENT-ASSETS>                                 2,615
<PP&E>                                          13,733
<DEPRECIATION>                                   7,173
<TOTAL-ASSETS>                                  12,818
<CURRENT-LIABILITIES>                            2,490
<BONDS>                                          4,371
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            73
<OTHER-SE>                                       3,448
<TOTAL-LIABILITY-AND-EQUITY>                    12,818
<SALES>                                         13,024
<TOTAL-REVENUES>                                13,024
<CGS>                                            9,933
<TOTAL-COSTS>                                    9,933
<OTHER-EXPENSES>                                   937
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 439
<INCOME-PRETAX>                                    296
<INCOME-TAX>                                       135
<INCOME-CONTINUING>                                161
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                    (5)
<CHANGES>                                            0
<NET-INCOME>                                       156
<EPS-PRIMARY>                                     1.71
<EPS-DILUTED>                                     1.71
        

</TABLE>
### §§401 to 411. Repealed. Pub. L. 86–613, §19, formerly §18, July 12, 1960, 74 Stat. 381; renumbered Pub. L. 91–113, §4(a), Nov. 6, 1969, 83 Stat. 189

Sections 401 to 411, act Mar. 4, 1927, ch. 489, §§1–10, 12, 44 Stat. 1406–1410, prohibited misbranded shipments of dangerous caustic or corrosive substances in interstate or foreign commerce. See chapter 30 [§1261 et seq.] of this title.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of Repeal; Savings Provision

Pub. L. 86–613, §19, formerly §18, July 12, 1960, 74 Stat. 381, renumbered and amended by Pub. L. 91–113, §4(a), (b)(2), Nov. 6, 1969, 83 Stat. 189, 190; Pub. L. 110–314, title II, §204(b)(4)(B), Aug. 14, 2008, 122 Stat. 3041, provided that: "The Federal Caustic Poison Act [sections 401 to 411 of this title] (44 Stat. 1406) is repealed effective at the close of the sixth calendar month after the month of enactment of this Act [July 12, 1960], except that the Federal Caustic Poison Act shall remain in full force and effect with respect to any 'dangerous caustic or corrosive substance' (as defined by that Act) which is an article subject to the Federal Food, Drug, and Cosmetic Act [chapter 9 of title 21] and which is, by virtue of paragraph 2 of section 2(f) of this Act [section 1261(f)(2) of this title], excluded from the term 'hazardous substance' as defined in this Act [chapter 30 of this title]: Provided, That, if the Commission, pursuant to section 17(b) of this Act [set out as a note under section 1261 of this title], prescribes an additional period or periods during which violations of this Act [chapter 30 of this title] shall not be enforceable and if such additional period or periods are applicable to violations of this Act [chapter 30 of this title] involving one or more substances defined as 'dangerous caustic or corrosive substances' by the Federal Caustic Poison Act, that Act shall, with respect to such substance or substances, remain in full force and effect during such additional period or periods; Provided further, That, with respect to violations, liabilities incurred or appeals taken prior to the close of said sixth month or, if applicable, prior to the expiration of the additional period or periods referred to in the preceding proviso, all provisions of the Federal Caustic Poison Act shall be deemed to remain in full force for the purpose of sustaining any proper suit, action, or other proceeding with respect to any such violations, liabilities, and appeals."
### §4021. Definitions

As used in this subchapter—

(1) the term "export trade" means trade or commerce in goods, wares, merchandise, or services exported, or in the course of being exported, from the United States or any territory thereof to any foreign nation,

(2) the term "service" means intangible economic output, including, but not limited to—

(A) business, repair, and amusement services,

(B) management, legal, engineering, architectural, and other professional services, and

(C) financial, insurance, transportation, informational and any other data-based services, and communication services,

(3) the term "export trade activities" means activities or agreements in the course of export trade,

(4) the term "methods of operation" means any method by which a person conducts or proposes to conduct export trade,

(5) the term "person" means an individual who is a resident of the United States; a partnership that is created under and exists pursuant to the laws of any State or of the United States; a State or local government entity; a corporation, whether organized as a profit or nonprofit corporation, that is created under and exists pursuant to the laws of any State or of the United States; or any association or combination, by contract or other arrangement, between or among such persons,

(6) the term "antitrust laws" means the antitrust laws, as such term is defined in section 12 of this title, and section 45 of this title (to the extent that section 45 of this title prohibits unfair methods of competition), and any State antitrust or unfair competition law,

(7) the term "Secretary" means the Secretary of Commerce or his designee, and

(8) the term "Attorney General" means the Attorney General of the United States or his designee.

(Pub. L. 97–290, title III, §311, Oct. 8, 1982, 96 Stat. 1245.)

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Section effective Oct. 8, 1982, see section 312 of Pub. L. 97–290, set out as a note under section 4011 of this title.
----

| Delaware                                                          |   | 000-23143               |   | 13-3379479                       |
|-------------------------------------------------------------------|--------|-------------------------|--------|----------------------------------|
| (State or other jurisdictionof incorporation)                     |   | (CommissionFile Number) |   | (IRS EmployerIdentification No.) |
|                                                              |   |                    |   |                             |
| 777 Old Saw Mill River Road, Tarrytown, New York                  |   | 10591                   |
| (Address of principal executive offices)                          |   | (Zip Code)              |
| Registrant's telephone number, including area code (914) 789-2800 |

----

| Item 8.01. | Other Events. |
|------------|---------------|

----

|   | PROGENICS PHARMACEUTICALS, INC. |
|--------|---------------------------------|
|   | By:                             | /s/ ANGELO W. LOVALLO, JR. |
|   |                            | Angelo W. Lovallo, Jr. |
|   |                            | Vice President, Finance & Treasurer |
|   |                            | (Principal Financial and Accounting Officer) |
biei_ex101.htm

EXHIBIT 10.1
 
FIRST AMENDMENT TO
SECURITIES PURCHASE AGREEMENT
 
This First Amendment to Securities Purchase Agreement (this "Amendment") is entered into on February 22, 2016 by and between Premier Biomedical, Inc., a Nevada corporation (the "Company") and Redwood Management, LLC (the "Purchaser").
 
RECITALS
 
WHEREAS, the Company and Purchaser are parties to that certain Securities Purchase Agreement dated as of December 28, 2015 (the "Agreement");
 
WHEREAS, the parties desire to amend the Agreement as set forth herein.
 
NOW, THEREFORE, for good and adequate consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
 
AGREEMENT
 
1. With respect to Section 2.1 of the Agreement, and specifically the funding of the third Tranche, the Purchaser hereby waives the requirement that the Company satisfy all of the Equity Conditions and instead has agreed to fund the third Tranche as follows:
 
		A. 	$75,000 on February 22, 2016;

		B. 	$75,000 on February 29, 2016; and

		C. 	$100,000 on March 7, 2016.



 
2. Other than as set forth herein, the terms and condition of the Agreement shall remain in full force and effect.
 
IN WITNESS WHEREOF, the parties have executed this Amendment on the date set forth above.
 
	"Company"
	 
	"Purchaser"
	 

	 
		 
	 
		 

	Premier Biomedical, Inc.
	 
	Redwood Management, LLC
	 

	 
		 
	 
		 

	By:
	/s/ William A. Hartman 
	 
	By:
	/s/ John DeNobile 
	 

	Name:
	William A. Hartman
	 
	Name:
	John DeNobile
	 

	Its:
	President
	 
	Its:
	Manager
### §80b–12. Hearings

Hearings may be public and may be held before the Commission, any member or members thereof, or any officer or officers of the Commission designated by it, and appropriate records thereof shall be kept.

(Aug. 22, 1940, ch. 686, title II, §212, 54 Stat. 855.)

#### **Executive Documents**

#### Transfer of Functions

For transfer of functions of Securities and Exchange Commission, with certain exceptions, to Chairman of such Commission, see Reorg. Plan No. 10 of 1950, §§1, 2, eff. May 24, 1950, 15 F.R. 3175, 64 Stat. 1265, set out under section 78d of this title.
<TABLE> <S> <C>

<ARTICLE>                          5
       
<S>                                <C>
<PERIOD-TYPE>                      12-MOS
<FISCAL-YEAR-END>                  DEC-31-1998
<PERIOD-END>                       DEC-31-1998
<CASH>                             321,725
<SECURITIES>                       0      
<RECEIVABLES>                      283,099  
<ALLOWANCES>                       0
<INVENTORY>                        0
<CURRENT-ASSETS>                   0
<PP&E>                             11,611,785     <F1>
<DEPRECIATION>                     620,134
<TOTAL-ASSETS>                     11,597,642
<CURRENT-LIABILITIES>              107,636
<BONDS>                            0            
<PREFERRED-MANDATORY>              0
<PREFERRED>                        0
<COMMON>                           11,490,006     <F2>
<OTHER-SE>                         0
<TOTAL-LIABILITY-AND-EQUITY>       11,597,642  
<SALES>                            0
<TOTAL-REVENUES>                   1,353,497      <F3>
<CGS>                              0
<TOTAL-COSTS>                      509,573        <F4>
<OTHER-EXPENSES>                   0
<LOSS-PROVISION>                   0
<INTEREST-EXPENSE>                 0 
<INCOME-PRETAX>                    0
<INCOME-TAX>                       0
<INCOME-CONTINUING>                0
<DISCONTINUED>                     0
<EXTRAORDINARY>                    0           
<CHANGES>                          0
<NET-INCOME>                       843,924
<EPS-PRIMARY>                      0
<EPS-DILUTED>                      0

<FN>
<F1>  "PP&E" REPRESENTS INVESTMENT IN REAL ESTATE [LAND AND
BUILDING]
<F2>   "COMMON" REPRESENTS TOTAL STOCKHOLDERS EQUITY
<F3>   "TOTAL REVENUES" REPRESENTS RENTAL, INTEREST, AND OTHER
INCOME
<F4>   "TOTAL COSTS" REPRESENTS TOTAL EXPENSES
</FN>
        

</TABLE>
#### § 93.322 Declaration for horses.

For all horses offered for importation from Mexico, the importer or his or her agent shall present two copies of a declaration as provided in § 93.305.

[55 FR 31495, Aug. 2, 1990. Redesignated and amended at 62 FR 56012, 56017, Oct. 28, 1997]
###### Editorial Note on Part 28

#### Editorial Note:

Nomenclature changes to part 28 appear at 76 FR 76873, Dec. 9, 2011.

#### § 28.145 Policy.

It is the policy of the Board to regulate strictly ex parte communications between members of the Board and their decision-making personnel and any interested party to a proceeding before the Board.
----

| Delaware                                                          |   | 000-23143               |   | 13-3379479                       |
|-------------------------------------------------------------------|--------|-------------------------|--------|----------------------------------|
| (State or other jurisdictionof incorporation)                     |   | (CommissionFile Number) |   | (IRS EmployerIdentification No.) |
|                                                              |   |                    |   |                             |
| 777 Old Saw Mill River Road, Tarrytown, New York                  |   | 10591                   |
| (Address of principal executive offices)                          |   | (Zip Code)              |
| Registrant's telephone number, including area code (914) 789-2800 |
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---------------------------------------------------------------------------------------|
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|---|----------------------------------------------------------------------------------------|
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|---|--------------------------------------------------------------------------------------------------------|
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|---|--------------------------------------------------------------------------------------------------------|

----

| Item 8.01. | Other Events. |
|------------|---------------|
| Item 9.01. | Financial Statements and Exhibits. |
|------------|------------------------------------|
| (d)   | Exhibits |
|-----------------|----------|
| Exhibit No. | Description |
|-------------|-------------|
| 99.1 | Press Release issued May 31, 2013. |
|------|------------------------------------|

----

|   | PROGENICS PHARMACEUTICALS, INC. |
|--------|---------------------------------|
|   | By:                             | /s/ ANGELO W. LOVALLO, JR. |
|   |                            | Angelo W. Lovallo, Jr. |
|   |                            | Vice President, Finance & Treasurer |
|   |                            | (Principal Financial and Accounting Officer) |
§ 35.27 Authority of State commissions. Nothing in this part— ( a ) Shall be construed as preempting or affecting any jurisdiction a State commission or other State authority may have under applicable State and Federal law, or
( b ) Limits the authority of a State commission in accordance with State and Federal law to establish ( 1 ) Competitive procedures for the acquisition of electric energy, including demand-side management, purchased at wholesale, or
( 2 ) Non-discriminatory fees for the distribution of such electric energy to retail consumers for purposes established in accordance with State law.
[Order 697, 72 FR 40038, July 20, 2007]
EXHIBIT 23

Consent
of Independent Registered Public Accounting Firm

We have issued our report dated
December 2, 2005, except for the last paragraph of Note 5, as to which the date is December 27,
2005, accompanying the consolidated financial statements included in the Annual
Report of Advanced Nutraceuticals, Inc. on Form 10-KSB for the year ended
September 30, 2005. We hereby consent to the incorporation by reference of said
report in the Registration Statement for Advanced Nutraceuticals, Inc. (the
successor to Nutrition For Life International, Inc.) on Form S-8 (File No.
33-99366, effective December 5, 1995).

/s/ GHP Horwath, P.C.GHP Horwath,
P.C. Denver, Colorado January 11, 2006

---
###### Editorial Note on Part 0

#### Editorial Note:

Nomenclature changes to part 0 appear at 73 FR 73 FR 54947, Sept. 24, 2008.

#### § 0.145 Overtime pay.

The Director of the Federal Bureau of Investigation, the Director of the Bureau of Prisons, the Commissioner of Federal Prison Industries, the Commissioner of Immigration and Naturalization, the Administrator of the Drug Enforcement Administration, the Director of the Bureau of Alcohol, Tobacco, Firearms, and Explosives, the Director of the Office of Justice Assistance, Research and Statistics and the Director of the U.S. Marshals Service as to their respective jurisdictions, and the Assistant Attorney General for Administration, as to all other organizational units of the Department (including U.S. Attorneys), may, subject to any regulations which the Attorney General may prescribe, authorize overtime pay (including additional compensation in lieu of overtime of not less than 10 percent nor more than 25 percent pursuant to section 5545(c)(2) of title 5, U.S. Code) for such positions as may be designated by them.

[Order No. 423-69, 34 FR 20388, Dec. 31, 1969, as amended by Order No. 516-73, 38 FR 12918, May 17, 1973; Order No. 520-73, 38 FR 18380, July 10, 1973; Order No. 960-81, 46 FR 52350, Oct. 27, 1981; Order No. 2650-2003, 68 FR 4928, Jan. 31, 2003]
<PAGE>   1
                                                                  EXHIBIT 23.1




                          INDEPENDENT AUDITORS' CONSENT



The Board of Directors
Jalate, Ltd.:

We consent to incorporation by reference in the registration statement on Form
S-8 of Jalate, Ltd. of our report dated March 3, 1998, relating to the balance
sheets of Linroz Manufacturing Company, L.P. as of December 31, 1996 and 1997
and the related statements of operations, partners' capital, and cash flows for
the two years then ended, which report appears in the December 31, 1997 annual
report on Form 10-K of Jalate, Ltd.



KPMG PEAT MARWICK LLP



Los Angeles, California
March 27, 1998
<PAGE>   1
                                                                      EXHIBIT 15




                    ACKNOWLEDGMENT OF INDEPENDENT ACCOUNTANTS


Board of Directors
The MIIX Group, Incorporated

We are aware of the incorporation by reference in the Registration Statement
(Form S-8) of The MIIX Group, Incorporated, pertaining to the amended and
restated 1998 Long Term Incentive Equity Plan of The MIIX Group, Incorporated,
of our report dated August 2, 2000 relating to the unaudited consolidated
interim financial statements of The MIIX Group, Incorporated and subsidiaries
included in this Form 10-Q filed on August 14, 2000 for the quarter ended June
30, 2000.

                                            ERNST & YOUNG LLP


New York, New York
August 2, 2000